1 Department of Nephrology, Abdominal Centre, Rigshospitalet, The Capital Region of Denmark2 Department of Nephrology, Herlev and Gentofte Hospital, The Capital Region of Denmark3 SUND ph.d. skole
Focus on non-classical effects and possible less side effects of treatment with nutritional vitamin D, raises the expectation of possible benefits from treating chronic kidney disease (CKD) patients with ergocalciferol (vitamin D2). Treatment with 1,25(OH)2 vitamin D (calcitriol) induces elevated fibroblast growth factor 23 (FGF23), while epidemiological studies have found positive effects of nutritional and 25(OH)vitamin D on mortality in CKD. Disturbed mineral homeostasis in CKD is correlated to adverse outcome and cardiovascular mortality. The objective was to examine the possible effects of treatment with high doses of ergocalciferol on parameters of mineral homeostasis in predialysis CKD patients.
Scandinavian Journal of Clinical and Laboratory Investigation, 2013, Vol 73, Issue 2, p. 107-16